Advisors Capital Management LLC Has $10.37 Million Stock Holdings in Danaher Corporation $DHR

Key Points

• Advisors Capital Management LLC increased its stake in Danaher Corporation by 10.8%, owning 50,587 shares worth approximately $10.37 million as of the latest quarter.
• Danaher's quarterly revenue rose 3.4% year-over-year to $5.94 billion, exceeding analysts' expectations, with the company reporting an EPS of $1.80.
• The company has a dividend yield of 0.7% with a declared quarterly dividend of $0.32, payable on October 31st, 2023.

Advisors Capital Management LLC grew its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 10.8% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 50,587 shares of the conglomerate's stock after purchasing an additional 4,930 shares during the period. Advisors Capital Management LLC's holdings in Danaher were worth $10,370,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. MGO One Seven LLC grew its holdings in Danaher by 485.7% in the first quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock worth $5,145,000 after purchasing an additional 20,813 shares during the period. Asahi Life Asset Management CO. LTD. purchased a new position in Danaher during the first quarter valued at approximately $539,000. Horizon Financial Services LLC lifted its position in Danaher by 20,400.0% during the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock valued at $1,681,000 after purchasing an additional 8,160 shares during the last quarter. UniSuper Management Pty Ltd lifted its position in Danaher by 1.6% during the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate's stock valued at $34,954,000 after purchasing an additional 2,667 shares during the last quarter. Finally, Texas Capital Bank Wealth Management Services Inc lifted its holdings in shares of Danaher by 6.1% in the 1st quarter. Texas Capital Bank Wealth Management Services Inc now owns 34,763 shares of the conglomerate's stock worth $7,126,000 after acquiring an additional 2,009 shares during the last quarter. Institutional investors own 79.05% of the company's stock.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of research analyst reports. Wells Fargo & Company reduced their price objective on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Wall Street Zen raised shares of Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Scotiabank raised shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price for the company in a report on Friday, July 11th. Finally, Barclays reaffirmed an "overweight" rating and set a $225.00 price objective (up from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Seventeen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $246.35.

Danaher Stock Up 1.4%

Shares of DHR opened at $195.23 on Friday. The stock has a fifty day simple moving average of $201.47 and a two-hundred day simple moving average of $199.04. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.90. The company has a market capitalization of $139.79 billion, a PE ratio of 41.54, a price-to-earnings-growth ratio of 2.69 and a beta of 0.75. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. During the same quarter last year, the business posted $1.72 EPS. The business's quarterly revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.7%. Danaher's payout ratio is 27.23%.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the business's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 11.10% of the company's stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.